Moreover, in rheumatoid arthritis, galectin-9 is higher in patients with severe disease, and responders display a significant decrease after treatment, both expression on lymphocytes and plasma levels (Sun J et al., 2021). The gene discussed is LGALS9; the disease is rheumatoid arthritis.